REPORT ID 3805

EMEA (Europe, Middle East and Africa) Narcotic Analgesics Market Report 2017

Publish Date
14-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the EMEA Narcotic Analgesics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Narcotic Analgesics for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Narcotic Analgesics market competition by top manufacturers/players, with Narcotic Analgesics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi S.A.
    Novartis AG
    GlaxoSmithKline PLC
    Pfizer
    Reckitt Benckiser
    Endo Pharmaceuticals
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Morphine
    Fentanyl
    Tramadol

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Medical Center
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Narcotic Analgesics Market Report 2017
1 Narcotic Analgesics Overview
    1.1 Product Overview and Scope of Narcotic Analgesics
    1.2 Classification of Narcotic Analgesics
        1.2.1 EMEA Narcotic Analgesics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Narcotic Analgesics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Morphine
        1.2.4 Fentanyl
        1.2.5 Tramadol
    1.3 EMEA Narcotic Analgesics Market by Application/End Users
        1.3.1 EMEA Narcotic Analgesics Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Medical Center
        1.3.4 Others
    1.4 EMEA Narcotic Analgesics Market by Region
        1.4.1 EMEA Narcotic Analgesics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Narcotic Analgesics (2012-2022)
        1.5.1 EMEA Narcotic Analgesics Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Narcotic Analgesics Revenue and Growth Rate (2012-2022)

2 EMEA Narcotic Analgesics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Narcotic Analgesics Market Competition by Players/Manufacturers
        2.1.1 EMEA Narcotic Analgesics Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Narcotic Analgesics Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Narcotic Analgesics Sale Price by Players (2012-2017)
    2.2 EMEA Narcotic Analgesics (Volume and Value) by Type/Product Category
        2.2.1 EMEA Narcotic Analgesics Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Narcotic Analgesics Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Narcotic Analgesics Sale Price by Type (2012-2017)
    2.3 EMEA Narcotic Analgesics (Volume) by Application
    2.4 EMEA Narcotic Analgesics (Volume and Value) by Region
        2.4.1 EMEA Narcotic Analgesics Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Narcotic Analgesics Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Narcotic Analgesics Sales Price by Region (2012-2017)

3 Europe Narcotic Analgesics (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Narcotic Analgesics Sales and Value (2012-2017)
        3.1.1 Europe Narcotic Analgesics Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Narcotic Analgesics Revenue and Growth Rate (2012-2017)
    3.2 Europe Narcotic Analgesics Sales and Market Share by Type
    3.3 Europe Narcotic Analgesics Sales and Market Share by Application
    3.4 Europe Narcotic Analgesics Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Narcotic Analgesics Sales Volume by Countries (2012-2017)
        3.4.2 Europe Narcotic Analgesics Revenue by Countries (2012-2017)
        3.4.3 Germany Narcotic Analgesics Sales and Growth Rate (2012-2017)
        3.4.4 France Narcotic Analgesics Sales and Growth Rate (2012-2017)
        3.4.5 UK Narcotic Analgesics Sales and Growth Rate (2012-2017)
        3.4.6 Russia Narcotic Analgesics Sales and Growth Rate (2012-2017)
        3.4.7 Italy Narcotic Analgesics Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Narcotic Analgesics Sales and Growth Rate (2012-2017)

4 Middle East Narcotic Analgesics (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Narcotic Analgesics Sales and Value (2012-2017)
        4.1.1 Middle East Narcotic Analgesics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Narcotic Analgesics Revenue and Growth Rate (2012-2017)
    4.2 Middle East Narcotic Analgesics Sales and Market Share by Type
    4.3 Middle East Narcotic Analgesics Sales and Market Share by Application
    4.4 Middle East Narcotic Analgesics Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Narcotic Analgesics Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Narcotic Analgesics Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Narcotic Analgesics Sales and Growth Rate (2012-2017)
        4.4.4 Israel Narcotic Analgesics Sales and Growth Rate (2012-2017)
        4.4.5 UAE Narcotic Analgesics Sales and Growth Rate (2012-2017)
        4.4.6 Iran Narcotic Analgesics Sales and Growth Rate (2012-2017)

5 Africa Narcotic Analgesics (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Narcotic Analgesics Sales and Value (2012-2017)
        5.1.1 Africa Narcotic Analgesics Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Narcotic Analgesics Revenue and Growth Rate (2012-2017)
    5.2 Africa Narcotic Analgesics Sales and Market Share by Type
    5.3 Africa Narcotic Analgesics Sales and Market Share by Application
    5.4 Africa Narcotic Analgesics Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Narcotic Analgesics Sales Volume by Countries (2012-2017)
        5.4.2 Africa Narcotic Analgesics Revenue by Countries (2012-2017)
        5.4.3 South Africa Narcotic Analgesics Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Narcotic Analgesics Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Narcotic Analgesics Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Narcotic Analgesics Sales and Growth Rate (2012-2017)

6 EMEA Narcotic Analgesics Manufacturers/Players Profiles and Sales Data
    6.1 Sanofi S.A.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Narcotic Analgesics Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi S.A. Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis AG
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Narcotic Analgesics Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis AG Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GlaxoSmithKline PLC
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Narcotic Analgesics Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GlaxoSmithKline PLC Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Narcotic Analgesics Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Reckitt Benckiser
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Narcotic Analgesics Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Reckitt Benckiser Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Endo Pharmaceuticals
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Narcotic Analgesics Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Endo Pharmaceuticals Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Narcotic Analgesics Manufacturing Cost Analysis
    7.1 Narcotic Analgesics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Narcotic Analgesics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Narcotic Analgesics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Narcotic Analgesics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Narcotic Analgesics Market Forecast (2017-2022)
    11.1 EMEA Narcotic Analgesics Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Narcotic Analgesics Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Narcotic Analgesics Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Narcotic Analgesics Price and Trend Forecast (2017-2022)
    11.2 EMEA Narcotic Analgesics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Narcotic Analgesics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Narcotic Analgesics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Narcotic Analgesics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Narcotic Analgesics Sales Forecast by Type (2017-2022)
    11.7 EMEA Narcotic Analgesics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer